Mitochondrial myopathy, not elsewhere classified. G71.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM G71.3 became effective on October 1, 2019.
Mitochondrial myopathies are a group of neuromuscular diseases caused by damage to the mitochondria. Symptoms include exercise intolerance and muscle weakness. Use our free symptom checker to find out if you have mitochondrial myopathy. What is mitochondrial myopathy?
In a patient with mitochondrial myopathy, the combined test will reveal a decrease in oxygen desaturation in the venous blood as mitochondrial dysfunction in skeletal muscle results in its inability to extract oxygen from blood [29]. Treatment for Mitochondrial Myopathies
In most cases, mitochondrial disease is a multisystem disorder affecting more than one type of cell, tissue, or organ. Because muscle and nerve cells have especially high energy needs, muscular and neurological problems are common features of mitochondrial disease.
Mitochondrial myopathies are a set of disorders involving abnormalities in mitochondria, which are structures within cells that are responsible for using oxygen to produce energy — often described as the powerhouses of the cells. Therefore, mitochondrial myopathies most commonly affect organs that consume a lot of oxygen such as muscles, the brain, ...
Muscle pain or weakness: The defining symptom of mitochondrial myopathies is muscle pain (myalgia) or weakness. The muscle symptoms more often affect the upper arms or thighs but can also affect the forearms or lower legs. These symptoms can develop rapidly or gradually.
Therefore, mitochondrial myopathies most commonly affect organs that consume a lot of oxygen such as muscles, the brain, and the heart. Symptoms may vary, but typically include muscle pain or weakness, double vision or blurry vision, droopy eyelids, difficulty breathing, and, in some forms, blindness, and seizures.
Mitochondrial myopathies caused by mutations in mitochondrial DNA can only be transmitted from the mother to her child because this type of DNA only comes from mothers. Mutations in mitochondrial DNA are responsible for disorders such as MELAS and Myoclonic Epilepsy with Ragged Red Fibers. Mutations in mitochondrial DNA can also cause Chronic Progressive External Ophthalmoplegia and Kearns-Sayre Syndrome.
Supplements to improve mitochondrial function and currently being studied include: Coenzyme Q10 : An important protein in mitochondrial function.
Specific treatments options include exercise, supplements, medications to prevent seizures, and surgery and various assistive devices for associated eye and breathing issues.
Treatment options include exercise, possible supplements, as well as procedures and assistive devices to address eye and breathing issues. Make an appointment with a physician to further analyze what genetic defects may be present, and begin prescription treatment .
Multisystemic inheritable disorders that involve skeletal muscle and are caused by dysfunction of mitochondrial oxidative phosphorylation.
Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.